Your browser doesn't support javascript.
loading
An efficient synthesis of 3-(N-piperidinemethyl)-2, 2, 5, 5-tetramethyl-1-oxy-3-pyrroline, a promising radioprotector for cancer radiotherapy.
Wu, Haitao; Coble, Vincent; Vasalatiy, Olga; Swenson, Rolf E; Krishna, Murali C; Mitchell, James B.
Afiliação
  • Wu H; Imaging Probe Development Center, National Heart, Lung, and Blood Institute, National Institutes of Health.
  • Coble V; Imaging Probe Development Center, National Heart, Lung, and Blood Institute, National Institutes of Health.
  • Vasalatiy O; Imaging Probe Development Center, National Heart, Lung, and Blood Institute, National Institutes of Health.
  • Swenson RE; Imaging Probe Development Center, National Heart, Lung, and Blood Institute, National Institutes of Health.
  • Krishna MC; Radiation Biology Branch, Center for Cancer Research, National Cancer Institute. National Institutes of Health.
  • Mitchell JB; Radiation Biology Branch, Center for Cancer Research, National Cancer Institute. National Institutes of Health.
Tetrahedron Lett ; 55(40): 5570-5571, 2014 Oct 01.
Article em En | MEDLINE | ID: mdl-25309004
Nitroxides can ameliorate the toxic effects of radiation during cancer therapy. Nitroxides are paramagnetic and can be used in magnetic resonance imaging (MRI) and electron paramagnetic resonance imaging (EPRI) to monitor in vivo oxidative stress status. Compound 5 (3-(N-piperidinemethyl)-2, 2, 5, 5-tetramethyl-1-oxy-3-pyrroline) was found to be the most effective nitroxide radioprotector. An efficient synthesis for this promising radioprotector was developed.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2014 Tipo de documento: Article